AQP4 and myeloid sarcoma: During this observation period, 11 patients remained idiopathic (six had a single event, and five had recurrent demyelinating disease inconsistent with MS or NMOSD), 11 patients developed AQP4-NMOSD, seven evolved into MS, and two had an alternative diagnosis.